• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小胶质细胞在多发性硬化症发病机制中的作用:协同还是拮抗?

Role of Microglial Cells in the Pathophysiology of MS: Synergistic or Antagonistic?

机构信息

Department of Neurology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 40-055 Katowice, Poland.

Department of Otorhinolaryngology and Oncological Laryngology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 40-055 Katowice, Poland.

出版信息

Int J Mol Sci. 2023 Jan 17;24(3):1861. doi: 10.3390/ijms24031861.

DOI:10.3390/ijms24031861
PMID:36768183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9916250/
Abstract

Many studies indicate an important role of microglia and their cytokines in the pathophysiology of multiple sclerosis (MS). Microglia are the macrophages of the central nervous system (CNS). They have many functions, such as being "controllers" of the CNS homeostasis in pathological and healthy conditions, playing a key role in the active immune defense of the CNS. Macroglia exhibit a dual role, depending on the phenotype they adopt. First, they can exhibit neurotoxic effects, which are harmful in the case of MS. However, they also show neuroprotective and regenerative effects in this disease. Many of the effects of microglia are mediated through the cytokines they secrete, which have either positive or negative properties. Neurotoxic and pro-inflammatory effects can be mediated by microglia via lipopolysaccharide and gamma interferon. On the other hand, the mediators of anti-inflammatory and protective effects secreted by microglia can be, for example, interleukin-4 and -13. Further investigation into the role of microglia in MS pathophysiology may perhaps lead to the discovery of new therapies for MS, as recent research in this area has been very promising.

摘要

许多研究表明小胶质细胞及其细胞因子在多发性硬化症(MS)的病理生理学中起着重要作用。小胶质细胞是中枢神经系统(CNS)的巨噬细胞。它们具有许多功能,例如在病理和生理条件下作为 CNS 内稳态的“控制器”,在 CNS 的主动免疫防御中发挥关键作用。巨胶质细胞表现出双重作用,具体取决于它们所采用的表型。首先,它们可以表现出神经毒性作用,在 MS 的情况下是有害的。然而,它们在这种疾病中也表现出神经保护和再生作用。小胶质细胞的许多作用是通过它们分泌的细胞因子介导的,这些细胞因子具有正或负的特性。通过脂多糖和γ干扰素,小胶质细胞可以介导神经毒性和促炎作用。另一方面,小胶质细胞分泌的抗炎和保护作用的介质可以是白细胞介素-4 和白细胞介素-13。对小胶质细胞在 MS 病理生理学中的作用的进一步研究可能会发现针对 MS 的新疗法,因为该领域的最新研究非常有前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d35/9916250/cb34ddbb2107/ijms-24-01861-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d35/9916250/200353cfffef/ijms-24-01861-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d35/9916250/b3c1a247df2c/ijms-24-01861-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d35/9916250/cb34ddbb2107/ijms-24-01861-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d35/9916250/200353cfffef/ijms-24-01861-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d35/9916250/b3c1a247df2c/ijms-24-01861-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d35/9916250/cb34ddbb2107/ijms-24-01861-g003.jpg

相似文献

1
Role of Microglial Cells in the Pathophysiology of MS: Synergistic or Antagonistic?小胶质细胞在多发性硬化症发病机制中的作用:协同还是拮抗?
Int J Mol Sci. 2023 Jan 17;24(3):1861. doi: 10.3390/ijms24031861.
2
Neuronal injury in chronic CNS inflammation.慢性中枢神经系统炎症中的神经元损伤。
Best Pract Res Clin Anaesthesiol. 2010 Dec;24(4):551-62. doi: 10.1016/j.bpa.2010.11.001. Epub 2010 Nov 29.
3
CSF1R signaling is a regulator of pathogenesis in progressive MS.CSF1R 信号是进行性 MS 发病机制的调节剂。
Cell Death Dis. 2020 Oct 23;11(10):904. doi: 10.1038/s41419-020-03084-7.
4
Fibronectin aggregates promote features of a classically and alternatively activated phenotype in macrophages.纤连蛋白聚集物促进巨噬细胞表现出经典激活和替代激活两种表型的特征。
J Neuroinflammation. 2018 Aug 2;15(1):218. doi: 10.1186/s12974-018-1238-x.
5
Identification of new therapeutic targets for prevention of CNS inflammation.确定预防中枢神经系统炎症的新治疗靶点。
Expert Opin Ther Targets. 2002 Apr;6(2):203-15. doi: 10.1517/14728222.6.2.203.
6
The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis.巨噬细胞和小胶质细胞在多发性硬化症和实验性自身免疫性脑脊髓炎中的作用。
J Neuroimmunol. 2018 May 15;318:1-7. doi: 10.1016/j.jneuroim.2018.02.015. Epub 2018 Feb 27.
7
Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype.木犀草素触发小胶质细胞转录组的全局变化,导致独特的抗炎和神经保护表型。
J Neuroinflammation. 2010 Jan 14;7:3. doi: 10.1186/1742-2094-7-3.
8
The Role of Distinct Subsets of Macrophages in the Pathogenesis of MS and the Impact of Different Therapeutic Agents on These Populations.不同巨噬细胞亚群在 MS 发病机制中的作用以及不同治疗药物对这些群体的影响。
Front Immunol. 2021 Aug 20;12:667705. doi: 10.3389/fimmu.2021.667705. eCollection 2021.
9
Drug-induced microglial phagocytosis in multiple sclerosis and experimental autoimmune encephalomyelitis and the underlying mechanisms.药物诱导的小胶质细胞吞噬作用在多发性硬化症和实验性自身免疫性脑脊髓炎中的作用及潜在机制。
Mol Biol Rep. 2023 Jan;50(1):749-759. doi: 10.1007/s11033-022-07968-z. Epub 2022 Oct 29.
10
Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies.早期多发性硬化病变为神经保护性治疗策略提供了新线索。
CNS Neurol Disord Drug Targets. 2011 Feb;10(1):68-81. doi: 10.2174/187152711794488566.

引用本文的文献

1
Neurotrophic factors in multiple sclerosis.多发性硬化症中的神经营养因子。
Front Immunol. 2025 Aug 27;16:1654603. doi: 10.3389/fimmu.2025.1654603. eCollection 2025.
2
Therapeutics Potential of Cronassial in Experimental Autoimmune Encephalomyelitis: Insights Into Glycosphingolipids and Humoral Immunity.克诺萨ial在实验性自身免疫性脑脊髓炎中的治疗潜力:对糖鞘脂和体液免疫的见解
ScientificWorldJournal. 2025 Jul 18;2025:9108462. doi: 10.1155/tswj/9108462. eCollection 2025.
3
Dementia in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis.

本文引用的文献

1
Bruton's Tyrosine Kinase Inhibition in Multiple Sclerosis.布劳顿酪氨酸激酶抑制剂在多发性硬化中的应用。
Curr Neurol Neurosci Rep. 2022 Nov;22(11):721-734. doi: 10.1007/s11910-022-01229-z. Epub 2022 Oct 27.
2
Microglia in multiple sclerosis: Protectors turn destroyers.多发性硬化症中的小胶质细胞:保护者变为破坏者。
Neuron. 2022 Nov 2;110(21):3534-3548. doi: 10.1016/j.neuron.2022.06.023. Epub 2022 Jul 25.
3
Microglia Phenotypes in Aging and Neurodegenerative Diseases.衰老和神经退行性疾病中的小胶质细胞表型。
多发性硬化症患者的痴呆症:系统评价与荟萃分析
Brain Behav. 2025 Jun;15(6):e70588. doi: 10.1002/brb3.70588.
4
Tyrosine kinase inhibitor, masitinib, limits neuronal damage, as measured by serum neurofilament light chain concentration in a model of neuroimmune-driven neurodegenerative disease.酪氨酸激酶抑制剂马西替尼可限制神经元损伤,这一损伤程度通过神经免疫驱动的神经退行性疾病模型中的血清神经丝轻链浓度来衡量。
PLoS One. 2025 May 14;20(5):e0322199. doi: 10.1371/journal.pone.0322199. eCollection 2025.
5
The Connection Between Oxidative Stress, Mitochondrial Dysfunction, Iron Metabolism and Microglia in Multiple Sclerosis: A Narrative Review.氧化应激、线粒体功能障碍、铁代谢与小胶质细胞在多发性硬化症中的联系:一项叙述性综述
NeuroSci. 2025 Mar 4;6(1):23. doi: 10.3390/neurosci6010023.
6
Novel Cell Models to Study Myelin and Microglia Interactions.用于研究髓鞘与小胶质细胞相互作用的新型细胞模型。
Int J Mol Sci. 2025 Feb 28;26(5):2179. doi: 10.3390/ijms26052179.
7
A Morphological Study of HLA-DR-Immunopositive Cells in Multiple Sclerosis Lesions and Their Implications for Pathogenesis.多发性硬化病变中HLA-DR免疫阳性细胞的形态学研究及其对发病机制的意义。
Diagnostics (Basel). 2024 Oct 8;14(19):2240. doi: 10.3390/diagnostics14192240.
8
Glial Cells as Key Regulators in Neuroinflammatory Mechanisms Associated with Multiple Sclerosis.胶质细胞作为与多发性硬化症相关的神经炎症机制中的关键调节者。
Int J Mol Sci. 2024 Sep 4;25(17):9588. doi: 10.3390/ijms25179588.
9
Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression.神经炎症和小胶质细胞激活的免疫学维度:探索创新的免疫调节方法以减轻神经炎症进展。
Front Immunol. 2024 Jan 8;14:1305933. doi: 10.3389/fimmu.2023.1305933. eCollection 2023.
10
Smouldering Lesion in MS: Microglia, Lymphocytes and Pathobiochemical Mechanisms.多发性硬化症中的潜伏性病灶:小胶质细胞、淋巴细胞和病理生物化学机制。
Int J Mol Sci. 2023 Aug 10;24(16):12631. doi: 10.3390/ijms241612631.
Cells. 2022 Jun 30;11(13):2091. doi: 10.3390/cells11132091.
4
Microglia Polarization From M1 to M2 in Neurodegenerative Diseases.神经退行性疾病中微胶质细胞从M1型向M2型极化
Front Aging Neurosci. 2022 Feb 16;14:815347. doi: 10.3389/fnagi.2022.815347. eCollection 2022.
5
The roles of microglia and astrocytes in phagocytosis and myelination: Insights from the cuprizone model of multiple sclerosis.小胶质细胞和星形胶质细胞在吞噬作用和髓鞘形成中的作用:多发性硬化症的铜绿假单胞菌模型的见解。
Glia. 2022 Jul;70(7):1215-1250. doi: 10.1002/glia.24148. Epub 2022 Feb 2.
6
Bruton's Tyrosine Kinase Inhibitors: A New Generation of Promising Agents for Multiple Sclerosis Therapy.布鲁顿酪氨酸激酶抑制剂:多发性硬化症治疗的新一代有前途药物。
Cells. 2021 Sep 27;10(10):2560. doi: 10.3390/cells10102560.
7
Anti-severe acute respiratory syndrome coronavirus-2 antibody responses following Pfizer-BioNTech vaccination in a patient with multiple sclerosis treated with ocrelizumab: a case report.在接受奥瑞珠单抗治疗的多发性硬化症患者中,辉瑞 - 生物科技公司疫苗接种后的抗严重急性呼吸综合征冠状病毒2抗体反应:一例报告
J Int Med Res. 2021 Sep;49(9):3000605211044378. doi: 10.1177/03000605211044378.
8
A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis.慢性活动性多发性硬化症中的淋巴细胞-小胶质细胞-星形胶质细胞轴。
Nature. 2021 Sep;597(7878):709-714. doi: 10.1038/s41586-021-03892-7. Epub 2021 Sep 8.
9
Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial.口服脑穿透 BTK 抑制剂替洛鲁替尼治疗复发性多发性硬化症的安全性和疗效:一项 2b 期、随机、双盲、安慰剂对照试验。
Lancet Neurol. 2021 Sep;20(9):729-738. doi: 10.1016/S1474-4422(21)00237-4.
10
Bruton's Tyrosine Kinase Inhibition in the Treatment of Preclinical Models and Multiple Sclerosis.布鲁顿酪氨酸激酶抑制在临床前模型和多发性硬化症治疗中的应用
Curr Pharm Des. 2022;28(6):437-444. doi: 10.2174/1381612827666210701152934.